Waters symmetry c18 column
The Waters Symmetry C18 column is a high-performance liquid chromatography (HPLC) column designed for the separation and analysis of a wide range of organic compounds. The column features a well-characterized, spherical C18 stationary phase that provides consistent and reliable chromatographic performance.
Lab products found in correlation
22 protocols using waters symmetry c18 column
Dopamine and DOPAC quantification
RP-HPLC Method for Olanzapine Quantification
Ecdysteroid Quantification in Lepidopteran Larvae
HPLC Quantification of Phytohormones
LC-MS/MS Quantification of Plasma Analytes
An ACQUITY UHPLC TM I-Class system (Waters, Milford, CT, USA) was employed to separate the analytes on a Waters Symmetry® C18 column (2.1 mm × 100 mm, 3.5 μm). The temperature of the column oven and sample tray were set at 40 °C and 10 °C, respectively. Methanol was used as mobile phase A and 2 mM ammonium acetate aqueous solution containing 0.1% formic acid was used as mobile phase B. A total flow rate of 0.2 mL/min was used, and the gradient program was performed as follows: 0–0.5, 95% B; 1.2–2.0 min, 5% B; 2.1–4.0 min, 95% B. The injection volume was set to 1 μL. Data acquisition and quantitative analyses were performed using a Waters TQ-S system (Waters MS Technologies, Manchester, UK). Multiple reaction monitoring (MRM) was employed to analyze the analytes and IS in positive polarity mode with electrospray ionization (ESI).
HPLC Analysis of Papaya Leaf Flavonoids
Evaluating STAT3 Inhibitors in Cancer Cells
Lipophilicity Investigation via HPLC
Quantitative Analysis of Respiratory Drugs
Bracketing standards of each of the drugs were made and run, and the accuracy of the standards was checked. System suitability was then checked by using five replicate injections of the bracketing standards. The relative standard deviations had to be either at or below 2%, and the USP tailing factor of the drug peak had to be no greater than the predetermined values (fluticasone propionate, budesonide, and beclomethasone dipropionate: 1.5, salbutamol sulfate and formoterol fumarate: 2.0) for the results of the run to be considered valid.
Urinary CYP3A Activity Determination
Cortisol and 6β-hydroxycortisol concentrations in urine were measured using Agilent 1290 Infinity (Agilent Technologies, Santa Clara, CA, USA) high-performance liquid chromatography with mass spectrometry. The isolation of drug and its metabolite was performed on Waters Symmetry C18 Column (150×4.6 mm; 5.0 μm, Waters Corporation, Milford, MA, USA). The column temperature was maintained at 35°C. UV detector wavelength was set at 246 nm. The mobile phase contained of 55% water formic acid solution (1 L of water:1 mL of formic acid) and 45% acetonitrile. The flow rate was 0.5 mL/min. Volumes of 10 μL were injected. The mass spectrometer was operated using the following conditions: positive polarity, MM-ES+APCI ionization.
CYP2C19 phenotyping using omeprazole and 5-hydroxyomeprazole concentrations in urine was described previously.17 (link)
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!